910297-61-9 Usage
Description
Dasatinib DiMeric IMpurity is an impurity of Dasatinib (D193600), a novel oral small-molecule Tyrosine Kinase Inhibitor (TKI) used for the treatment of Chronic Myeloid Leukemia (CML). It is also classified as an Antineoplastic agent and has been identified as a COVID-19 related research product.
Uses
Used in Pharmaceutical Industry:
Dasatinib DiMeric IMpurity is used as a research compound for the development and improvement of cancer treatments, specifically for Chronic Myeloid Leukemia (CML). Its role as an impurity in Dasatinib allows researchers to study the effects and interactions of the compound in the treatment process.
Used in Anticancer Applications:
As an Antineoplastic agent, Dasatinib DiMeric IMpurity contributes to the development of cancer-fighting drugs and therapies, potentially enhancing the effectiveness of Dasatinib in treating CML.
Used in COVID-19 Research:
Dasatinib DiMeric IMpurity is utilized as a research product in the study of COVID-19, exploring its potential applications and effects in relation to the virus and associated treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 910297-61-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,2,9 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 910297-61:
(8*9)+(7*1)+(6*0)+(5*2)+(4*9)+(3*7)+(2*6)+(1*1)=159
159 % 10 = 9
So 910297-61-9 is a valid CAS Registry Number.
910297-61-9Relevant articles and documents
'N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites
-
Page/Page column 28, (2008/06/13)
The present invention is directed to metabolites of ′N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, the compound of formula (I), pharmaceutical compositions thereof, and to methods
